Protein kinase inhibitors for the treatment of cancer
- 31 August 1996
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 1 (8) , 325-330
- https://doi.org/10.1016/1359-6446(96)10030-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Inhibition of acute lymphoblastic leukaemia by a Jak-2 inhibitorNature, 1996
- PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in VivoJournal of Biological Chemistry, 1995
- A Specific Inhibitor of the Epidermal Growth Factor Receptor Tyrosine KinaseScience, 1994
- A Cell Cycle Regulator Potentially Involved in Genesis of Many Tumor TypesScience, 1994
- Protein kinase C - a question of specificityTrends in Biochemical Sciences, 1994
- C-erbB-2 overexpression in primary breast cancer: independent prognostic factor in patients at high riskBreast Cancer Research and Treatment, 1994
- Absence of Activating Mutations of the RAF1 Protooncogene in Human Lung CancerBiological Chemistry Hoppe-Seyler, 1994
- Expression of c-erbB-2 in in situ and in Adjacent Invasive Ductal Adenocarcinomas of the FemalePathobiology, 1992
- Stimulation by EGF of the growth of EGF receptor‐hyperproducing tumor cells in athymic miceInternational Journal of Cancer, 1987
- Staurosporine, a potent inhibitor of phospholipidCa++dependent protein kinaseBiochemical and Biophysical Research Communications, 1986